Visudyne

Visudyne (verteporfin) is an intravenous medication used in photodynamic therapy for certain eye conditions. This light-activated drug targets abnormal blood vessels in the retina. Commonly prescribed for age-related macular degeneration. Always consult a healthcare provider for personalized guidance.

Visudyne (verteporfin) is primarily used in photodynamic therapy to treat eye conditions caused by abnormal blood vessel growth, such as wet age-related macular degeneration. It may also be used for other retinal disorders as determined by a healthcare professional. This medication works when activated by a specific type of light during a medical procedure.

After administration, verteporfin circulates in the bloodstream and accumulates in abnormal blood vessels. When exposed to a low-energy laser light during treatment, it becomes active and helps close off these abnormal vessels. Patients may experience temporary sensitivity to light following the procedure.

Avoid direct sunlight or bright indoor light for at least 48 hours after treatment to prevent skin reactions. Wear protective clothing and sunglasses when outdoors. Inform your doctor about all medications and medical conditions before receiving Visudyne. This drug should only be administered by trained healthcare professionals.

Verteporfin may interact with other light-sensitive drugs or supplements. Avoid herbal products like St. John’s wort, which can increase photosensitivity. Discuss all current medications, including over-the-counter drugs, with your doctor. No major drug-drug interactions are widely reported, but caution is advised with photosensitizing agents.